It is speculated in this study that IL6, MMP9, CXCL8 and IL1B may contribute to the occurrence and development of CRC and NAFLD, and may be potentially candidate markers. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.